Malaria Vaccines Revolutionize Child Health in Ghana, Expand Across Africa
February 6, 2026·2 min
The episode reports on the impact of malaria vaccines in Ghana, where shots from GSK and Oxford University with the Serum Institute of India have helped slash child mortality. Dr. Salorm Kutsuadi, head of Ghana's immunization program, credits these vaccines with closing remaining gaps in the fight against malaria. The World Health Organization announced support for seven new countries to introduce malaria vaccines, raising the total to 24 nations. This rollout is part of broader efforts against diseases like HPV and polio. A Phase 2 trial published in Malaria World tested the Pro6C-ALOH-MatrixM vaccine in African adults with lifelong malaria exposure, evaluating its efficacy and safety. Funding cuts by the Trump administration and other wealthy donors, as warned by Gavi and Reuters, could limit vaccine access for children in malaria's epicenter. In conflict-hit Mali, Gavi reports that training all 76 community health workers in Djené as vaccinators has boosted immunization rates. This initiative serves 41% of the district's population and improves equity. The episode highlights both the progress and challenges in malaria vaccination across Africa. It combines data from recent reports, including those from Gavi and the Japan Times. The narrative moves from success stories in Ghana to expansion efforts and scientific trials. It then addresses funding threats and showcases adaptive strategies in insecure regions like Mali. The episode provides a comprehensive view of current malaria vaccine dynamics.
